Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Family

Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming 
Deadlines in Shareholder Litigation Involving Family Dollar
Stores, Inc. and Incyte Corporation 
ATLANTA, GA -- (Marketwired) -- 04/15/13 --  Holzer Holzer & Fistel
LLC reminds investors of upcoming deadlines for applications to serve
as lead plaintiff in securities class action lawsuits against Family
Dollar Stores, Inc. (FDO) and Incyte Corporation (INCY). 
Investors that suffered significant losses investing in either of
these companies during the specified times who are interested in
potentially serving as lead plaintiff in the respective class actions
are encouraged to contact Michael I. Fistel, Jr., Esq.
(mfistel@holzerlaw.com) or Marshall P. Dees, Esq.
(mdees@holzerlaw.com) by email or via toll-free telephone at (888)
508-6832 to discuss their legal rights. 
Family Dollar Stores, Inc. 
A class action lawsuit has been filed on behalf of investors who
purchased Family Dollar (NYSE: FDO) common stock between October 3,
2012 and January 2, 2013. The lawsuit alleges the company violated
the federal securities laws by, among other things, failing to
adequately disclose softening demand for its higher-end discretionary
items compared to its lower margin consumables which, according to
the complaint, resulted in lower profits and a buildup of merchandise
that negatively impacts profitability. 
The deadline to seek appointment as lead plaintiff in this lawsuit,
which is pending in the United States District Court for the Western
District of North Carolina, is April 22, 2013. More information about
the lawsuit and the firm are available at www.holzerlaw.com. 
Incyte Corporation 
A class action lawsuit has been filed on behalf of investors who
purchased Incyte (NASDAQ: INCY) common stock between April 26, 2012
and August 1, 2012, inclusive, alleging the company violated the
federal securities laws by making false and misleading statements to
investors regarding, among other things, demand for its drug Jakafi
(ruxolitinib). 
The deadline to seek appointment as lead plaintiff in this lawsuit,
which is pending in the United States District Court for the District
of Delaware, is May 6, 2013. More information about the lawsuit and
the firm are available at www.holzerlaw.com. 
About The Firm 
Holzer Holzer & Fistel, LLC dedicates its practice to vigorous
representation of shareholders and investors in litigation
nationwide, including shareholder class action and derivative
litigation. More information about the firm is available through its
website, www.holzerlaw.com and upon request from the firm. Holzer
Holzer & Fistel, LLC has paid for the dissemination of this
promotional communication, and Michael I. Fistel, Jr. is the attorney
responsible for its content. 
CONTACT: 
Michael I. Fistel, Jr., Esq.
Marshall P. Dees, Esq.
Holzer Holzer & Fistel, LLC
200 Ashford Center North, Suite 300
Atlanta, GA 30338
(888) 508-6832 (toll-free)
mfistel@holzerlaw.com 
mdees@holzerlaw.com